This may be due to the intrinsic differences between European and Japanese patients, with European CTEPH patients having higher serum concentrations of C-reactive protein, fibrinogen, and myeloperoxidase and more red thrombus than Japanese CTEPH patients [41]. This evidence concerns the gene MPO and chronic thromboembolic pulmonary hypertension.